Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

5 treatments under study, led by Xenogenic Bone Graft Material

Research Leaders

6 sponsors active, led by The European Research Group on Periodontology (ERGOPerio)

Related Conditions

Often studied with 4 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

3Total
Not Applicable (3)

Trial Status

Completed2
Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (3)

Research Network

Common Treatments

  • Xenogenic Bone Graft Material1
  • Labrida Bioclean1
  • Tooth Extraction And Replacement1
  • Enamel Matrix Derivative Bone Replacement Graft Barrier Membrane1
  • Emdogain Fl1

Active Sponsors

  • The European Research Group on Periodontology (ERGOPerio)1
  • University of Ljubljana1
  • University of Turku1
  • University of Oslo1
  • Riga Stradins University1

Top Investigators

Related Conditions

  • Periodontitis Adult1
  • Furcation Of Root Of Tooth1
  • Xenograft Model1
  • Furcation Defects1

Activity Timeline